Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript May 14, 2026
Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.33, expectations were $-1.885.
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today’s conference call may be recorded. I would now like to hand the conference call over to Anne Marie Fields, Managing Director at Precision AQ. Please go ahead.
Anne Marie...
